Maxwell Biotech, Sequella enter license agreement to commercialize SQ109 for TB treatment.....
Med-Chemist : "Quintessential Medicinal Chemistry"
Sunday, May 1, 2011
Maxwell Biotech, Sequella enter license agreement to commercialize SQ109 for TB treatment
Maxwell Biotech, Sequella enter license agreement to commercialize SQ109 for TB treatment.....
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment